Trade Summary

3 days ago, Sayad Pierre Sargis, serving as Chief Medical Officer at FENNEC PHARMACEUTICALS INC. (FENC), sold 12,000 shares at $12.18 per share, for a total transaction value of $146,160.00. Following this transaction, Sayad Pierre Sargis now holds 9,519 shares of FENC.

This sale represents a 55.76% decrease in Sayad Pierre Sargis's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, August 31, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, September 1, 2026 (accepted Aug 31, 8:15 PM ET), 1 day after the trade was made.

FENNEC PHARMACEUTICALS INC. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.